(Q48442504)

11 February 2018

title

Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. (English)

1 reference

11 February 2018

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

ventricular remodeling

1 reference

Yasuyuki Onai

1

1 reference

11 February 2018

Jun-Ichi Suzuki

2

1 reference

11 February 2018

Yasuhiro Maejima

3

1 reference

11 February 2018

Go Haraguchi

4

1 reference

11 February 2018

Susumu Muto

5

1 reference

11 February 2018

Akiko Itai

6

1 reference

11 February 2018

Mitsuaki Isobe

7

1 reference

11 February 2018

publication date

18 August 2006

1 reference

11 February 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

11 February 2018

volume

292

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

H530-8

1 reference

11 February 2018

Transforming growth factor beta in tissue fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

NF-kappaB regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Mechanisms and models in heart failure: A combinatorial approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Estimation of left ventricular end-diastolic pressure from Doppler transmitral flow velocity in cardiac patients independent of systolic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00549.2006

10.1152/AJPHEART.00549.2006

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018